Cotinga Pharmaceuticals Inc.
COTQF · OTC
4/30/2019 | 4/30/2018 | 4/30/2017 | 4/30/2016 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.01 | 0.00 | -0.18 |
| FCF Yield | -787.40% | -563.20% | -80.56% | -62.76% |
| EV / EBITDA | -0.07 | -0.08 | -0.63 | -0.84 |
| Quality | ||||
| ROIC | 125.04% | 396.19% | -843.76% | -100.83% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.63 | 0.78 | 0.72 | 0.73 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 58.47% | 11.32% | -11.29% | -122,687.69% |
| Safety | ||||
| Net Debt / EBITDA | 0.01 | 0.01 | 0.09 | 0.44 |
| Interest Coverage | 0.00 | -3,428.44 | -2,199.04 | -3,207.84 |
| Efficiency | ||||
| Inventory Turnover | 85,683.44 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |